449 related articles for article (PubMed ID: 28808996)
1. Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.
Prieto DA; Chan KC; Johann DJ; Ye X; Whitely G; Blonder J
Methods Mol Biol; 2017; 1647():71-90. PubMed ID: 28808996
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Prieto DA; Johann DJ; Wei BR; Ye X; Chan KC; Nissley DV; Simpson RM; Citrin DE; Mackall CL; Linehan WM; Blonder J
Biomark Med; 2014; 8(2):269-86. PubMed ID: 24521024
[TBL] [Abstract][Full Text] [Related]
3. Protocol for the Analysis of Laser Capture Microdissected Fresh-Frozen Tissue Homogenates by Silver-Stained 1D SDS-PAGE.
Prieto DA; Whitely G; Johann DJ; Blonder J
Methods Mol Biol; 2018; 1723():95-110. PubMed ID: 29344855
[TBL] [Abstract][Full Text] [Related]
4. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.
Linke T; Doraiswamy S; Harrison EH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):273-81. PubMed ID: 17188586
[TBL] [Abstract][Full Text] [Related]
5. Identification of Post-Translational Modifications from Serum/Plasma by Immunoaffinity Enrichment and LC-MS/MS Analysis Without Depletion of Abundant Proteins.
Gu H; Ren J; Jia X; Stokes MP
Methods Mol Biol; 2017; 1619():119-125. PubMed ID: 28674881
[TBL] [Abstract][Full Text] [Related]
6. Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry.
Dittrich J; Becker S; Hecht M; Ceglarek U
Proteomics Clin Appl; 2015 Feb; 9(1-2):5-16. PubMed ID: 25418444
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive proteome analysis of fresh frozen and optimal cutting temperature (OCT) embedded primary non-small cell lung carcinoma by LC-MS/MS.
Zhang W; Sakashita S; Taylor P; Tsao MS; Moran MF
Methods; 2015 Jun; 81():50-5. PubMed ID: 25721092
[TBL] [Abstract][Full Text] [Related]
8. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion.
Liu Z; Fan S; Liu H; Yu J; Qiao R; Zhou M; Yang Y; Zhou J; Xie P
PLoS One; 2016; 11(11):e0166306. PubMed ID: 27832179
[TBL] [Abstract][Full Text] [Related]
10. GeLC-MS: A Sample Preparation Method for Proteomics Analysis of Minimal Amount of Tissue.
Makridakis M; Vlahou A
Methods Mol Biol; 2018; 1788():165-175. PubMed ID: 28994030
[TBL] [Abstract][Full Text] [Related]
11. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
12. Immunoaffinity separation of plasma proteins by IgY microbeads: meeting the needs of proteomic sample preparation and analysis.
Huang L; Harvie G; Feitelson JS; Gramatikoff K; Herold DA; Allen DL; Amunngama R; Hagler RA; Pisano MR; Zhang WW; Fang X
Proteomics; 2005 Aug; 5(13):3314-28. PubMed ID: 16041669
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.
Liu T; Qian WJ; Mottaz HM; Gritsenko MA; Norbeck AD; Moore RJ; Purvine SO; Camp DG; Smith RD
Mol Cell Proteomics; 2006 Nov; 5(11):2167-74. PubMed ID: 16854842
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
15. Clinical Proteomics: Liquid Chromatography-Mass Spectrometry (LC-MS) Purification Systems.
Henry M; Meleady P
Methods Mol Biol; 2017; 1485():375-388. PubMed ID: 27730564
[TBL] [Abstract][Full Text] [Related]
16. Mass Spectrometry-Based Serum Proteomics for Biomarker Discovery and Validation.
Bhosale SD; Moulder R; Kouvonen P; Lahesmaa R; Goodlett DR
Methods Mol Biol; 2017; 1619():451-466. PubMed ID: 28674903
[TBL] [Abstract][Full Text] [Related]
17. Urinary proteome profiling using 2D-DIGE and LC-MS/MS.
Weeks ME
Methods Mol Biol; 2010; 658():293-309. PubMed ID: 20839112
[TBL] [Abstract][Full Text] [Related]
18. Performance evaluation of affinity ligands for depletion of abundant plasma proteins.
Kullolli M; Warren J; Arampatzidou M; Pitteri SJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():10-6. PubMed ID: 24090752
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Linke T; Ross AC; Harrison EH
J Chromatogr A; 2006 Aug; 1123(2):160-9. PubMed ID: 16472533
[TBL] [Abstract][Full Text] [Related]
20. A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS.
Ye H; Sun L; Huang X; Zhang P; Zhao X
Mol Cell Biochem; 2010 Oct; 343(1-2):91-9. PubMed ID: 20526653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
